Clinical Trial Update: A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of Evogliptin/metformin XR (DA-1229_01) 2.5/500 mg tablets compared with co-administrati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Evogliptin/metformin XR (DA-1229_01) (evogliptin/metformin extended-release combination)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED